Successful unrelated bone marrow transplantation in beta-thalassaemia. 1994

L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
Istituto di Clinica Medica, Università di Cagliari, Italy.

A 16-year-old Sardinian girl affected by homozygous beta-thalassaemia was submitted to allogeneic BMT using an HLA-identical, MLC-negative, unrelated donor. The donor and the patient were homozygous for the entire extended haplotype A30, Cw5, B18, F130, DRB1*0301, DRB3*0202, DQA1*0501, DQB1*0201 and heterozygous for DPB1*0301/DPB1*0202. The conditioning regimen consisted of 14 mg/kg busulphan and 160 mg/kg cyclophosphamide. Engraftment was achieved 14 days from BMT and the haematological reconstitution was complete without any signs of acute or chronic GVHD. Seven months after the transplant the patient was in excellent general condition. The hypothesis is advanced that when two HLA extended haplotypes are shared by donors and recipients, particularly in homozygosity, this is a very favourable immunogenetic condition in unrelated BMT.

UI MeSH Term Description Entries
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
July 1996, Bone marrow transplantation,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
October 2002, Journal of pediatric hematology/oncology,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
January 2001, Bone marrow transplantation,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
May 1986, Bone marrow transplantation,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
February 2004, Bone marrow transplantation,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
October 2004, JPMA. The Journal of the Pakistan Medical Association,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
March 2001, Bone marrow transplantation,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
March 1986, The Medical journal of Australia,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
January 1997, Journal of internal medicine. Supplement,
L Contu, and G La Nasa, and M Arras, and A Ledda, and A Pizzati, and A Vacca, and C Carcassi, and L Floris, and R Porcella, and S Orrù
November 2012, Pediatric transplantation,
Copied contents to your clipboard!